HUP0302790A2 - SI (Helicobacter pylori) receptorok és alkalmazásuk - Google Patents

SI (Helicobacter pylori) receptorok és alkalmazásuk

Info

Publication number
HUP0302790A2
HUP0302790A2 HU0302790A HUP0302790A HUP0302790A2 HU P0302790 A2 HUP0302790 A2 HU P0302790A2 HU 0302790 A HU0302790 A HU 0302790A HU P0302790 A HUP0302790 A HU P0302790A HU P0302790 A2 HUP0302790 A2 HU P0302790A2
Authority
HU
Hungary
Prior art keywords
helicobacter pylori
nac
novel receptors
subject
receptor
Prior art date
Application number
HU0302790A
Other languages
English (en)
Inventor
Jonas Angström
Karl-Anders Karlsson
Halina Miller-Podraza
Jari Natunen
Susann Teneberg
Original Assignee
Biotie Therapies Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp. filed Critical Biotie Therapies Corp.
Publication of HUP0302790A2 publication Critical patent/HUP0302790A2/hu
Publication of HUP0302790A3 publication Critical patent/HUP0302790A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A találmány tárgya Helicobacter pylorihoz kötődő oligoszaccharid-szekvenciát tartalmazó anyag vagy receptor, amelynek a szekvenciájaGal(A)q(NAc)r/Glc(A)q(NAc)ra3/b3]s[Galb4GlcNAcb3]t Galb4Glc(NAc)u,ahol q, r, s, t és u értéke egymástól függetlenül 0 vagy1; és annakalkalmazása, például gyógyászati és táplálék készítményekben,Helicobacter pylori jelenléte miatti állapotok kezelésére. A találmánytárgyát képezi továbbá a receptor alkalmazása Helicobacter pyloridiagnosztizálására. Ó
HU0302790A 2001-01-19 2002-01-18 Novel receptors for si(helicobacter pylori) and use thereof HUP0302790A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010118A FI20010118A (fi) 2001-01-19 2001-01-19 Uudet helicobacter pylori reseptorit ja niiden käyttö
PCT/FI2002/000043 WO2002056893A1 (en) 2001-01-19 2002-01-18 Novel receptors for $i(helicobacter pylori) and use thereof

Publications (2)

Publication Number Publication Date
HUP0302790A2 true HUP0302790A2 (hu) 2003-11-28
HUP0302790A3 HUP0302790A3 (en) 2010-01-28

Family

ID=8560066

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302790A HUP0302790A3 (en) 2001-01-19 2002-01-18 Novel receptors for si(helicobacter pylori) and use thereof

Country Status (19)

Country Link
US (1) US20040096465A1 (hu)
EP (1) EP1359922A1 (hu)
JP (1) JP2004519459A (hu)
KR (1) KR100886777B1 (hu)
CN (1) CN100455290C (hu)
AU (1) AU2002229792B2 (hu)
CA (1) CA2434350A1 (hu)
CZ (1) CZ20031914A3 (hu)
EE (1) EE200300339A (hu)
FI (1) FI20010118A (hu)
HU (1) HUP0302790A3 (hu)
IL (1) IL156992A0 (hu)
NO (1) NO20033270L (hu)
NZ (1) NZ526906A (hu)
PL (1) PL363617A1 (hu)
RU (1) RU2306140C2 (hu)
SK (1) SK10042003A3 (hu)
WO (1) WO2002056893A1 (hu)
ZA (1) ZA200305155B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20011671A (fi) 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
US20050220819A1 (en) * 2002-01-18 2005-10-06 Biotie Therapies Oyj Novel binding epitopes for helicobacter pylori and use thereof
EP1531832B1 (en) * 2002-06-28 2009-04-15 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
WO2004065400A1 (en) * 2003-01-20 2004-08-05 Glykos Finland Oy Novel binding epitopes for helicobacter pylori and use thereof
JP5035787B2 (ja) * 2005-10-04 2012-09-26 焼津水産化学工業株式会社 α−１、４結合型Ｎ−アセチルグルコサミン含有Ｏ−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
JP5140246B2 (ja) * 2006-03-15 2013-02-06 公益財団法人野口研究所 Ｎ−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
US8075674B2 (en) 2006-11-30 2011-12-13 Donaldson Company, Inc. Filter apparatus with pulse cleaning and methods for pulse cleaning filters
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
CA2705014A1 (en) * 2007-11-08 2009-05-14 Nestec S.A. Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
CN104321079A (zh) * 2012-03-19 2015-01-28 马普科技促进协会 糖类-糖脂类缀合物疫苗
WO2014070709A1 (en) * 2012-10-29 2014-05-08 The Board Of Trustees Of The University Of Arkansas Novel mucosal adjuvants and delivery systems
CN112023037A (zh) * 2020-09-09 2020-12-04 四川大学 一种聚糖在制备对Hp感染的预防和治疗产品中的应用、产品及制备方法
CN112285338B (zh) * 2020-10-20 2023-04-28 四川大学华西医院 一种copd诊断试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof

Also Published As

Publication number Publication date
CA2434350A1 (en) 2002-07-25
RU2003125370A (ru) 2005-02-10
SK10042003A3 (sk) 2003-11-04
US20040096465A1 (en) 2004-05-20
PL363617A1 (en) 2004-11-29
RU2306140C2 (ru) 2007-09-20
JP2004519459A (ja) 2004-07-02
WO2002056893A1 (en) 2002-07-25
EP1359922A1 (en) 2003-11-12
NO20033270L (no) 2003-09-19
KR100886777B1 (ko) 2009-03-04
ZA200305155B (en) 2004-07-19
KR20040018329A (ko) 2004-03-03
FI20010118A (fi) 2002-07-20
CN1525862A (zh) 2004-09-01
NO20033270D0 (no) 2003-07-18
FI20010118A0 (fi) 2001-01-19
IL156992A0 (en) 2004-02-08
NZ526906A (en) 2005-03-24
AU2002229792B2 (en) 2007-08-16
CZ20031914A3 (cs) 2004-04-14
WO2002056893A8 (en) 2003-11-13
CN100455290C (zh) 2009-01-28
EE200300339A (et) 2003-10-15
HUP0302790A3 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
HUP0302790A2 (hu) SI (Helicobacter pylori) receptorok és alkalmazásuk
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
HUP0402653A2 (hu) Interleukin 15-re (IL-15-re) specifikus emberi antitestek
HUP0401591A2 (hu) Új receptor-nukleinsavak és- polipeptidek
EP2085096A3 (en) Novel composition and methods for the treatment of immune related diseases
EP1855719A4 (en) NEUTRALIZING MONOCLONAL ANTIBODIES TO CORONAVIRES IN CONNECTION WITH HEAVY ACUTE RESPIRATORY SYNDROME
WO2000053758A3 (en) Compositions and methods for the treatment of immune related diseases
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
HK1065323A1 (en) Human dr4 antibodies and uses thereof
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
WO2000073452A3 (en) Compositions and methods for the treatment of immune related diseases
HUP0301349A2 (hu) IL-11-tartalmú készítmények
HUP0303194A2 (hu) DKK-1 és antagonistái alkalmazásai
WO2003016915A8 (en) Tumor specific oligosaccharide sequences and use thereof
EP1412388A4 (en) HUMANIZED ANTIBODIES DERIVED FROM DD-3B6 / 22, SPECIFIC OF THE FIBRIN D-DIMER FRAGMENT
DE59608213D1 (de) Arzneimittel zur immuntherapie, enthaltend antikörper, die spezifisch das mhcii-antigen eines zu behandelnden patienten erkennen
AU7635396A (en) Treatment and diagnosis of infections due to helicobacter pylori
HUP0402173A2 (hu) Eljárások izomtömeg vagy -funkció szabályozására szolgáló vegyületek azonosítására
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
HK1025793A1 (en) Hepatitis c receptor protein cd81
WO2004081199A3 (en) Novel compositions and methods for the treatment of immune related disease
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
BR9916549A (pt) Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
BR0211991A (pt) HormÈnio do crescimento humano modificado

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees